76 studies found for:    "Kidney Diseases, Cystic"
Show Display Options
Rank Status Study
1 Recruiting Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Conditions: Cystic Renal Diseases;   Kidney Neoplasms
Interventions: Other: Blood/urine sampling;   Other: Conventional routine CT examination;   Other: Contrast-enhanced renal ultrasonography (CEUS);   Other: Functional MRI
2 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
3 Unknown  UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
4 Completed Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: pravastatin;   Drug: Placebo
5 Completed Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome
Conditions: Joubert Syndrome;   Cerebello-oculo-renal Syndromes
Intervention: Biological: Whole blood sample
6 Completed Tolvaptan Open-Label Pilot Efficacy, Tolerability and Safety Study in ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: tolvaptan
7 Unknown  Clinical Trial to Slow the Progression of ADPKD
Conditions: Kidney, Polycystic;   Kidney, Polycystic, Autosomal Dominant
Intervention: Drug: anti-hypertensive medications
8 Completed Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tetracosactin
9 Recruiting Dismembered Pyeloplasty With and Without After Coming Stent
Conditions: Pelviureteric Junction Obstruction;   Pyeloplasty;   Neonate Affected by Hydronephrosis;   Obstructive Uropathy;   Urinary Stent
Interventions: Procedure: After coming stent after dismembered pyeloplasty;   Procedure: Stentless dismembered pyeloplasty
10 Unknown  High Water Intake to Slow Progression of Polycystic Kidney Disease
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Other: Water
11 Unknown  Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction
Conditions: Hydronephrosis;   Multicystic-Dysplastic Kidney
Intervention: Device: 24-hour ambulatory blood pressure monitor
12 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
13 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
Intervention:
14 Active, not recruiting A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: OPC-41061
15 Completed
Has Results
Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Placebo;   Drug: Everolimus
16 Recruiting Sirolimus for Massive Polycystic Liver
Condition: Polycystic Kidney Diseases
Intervention: Drug: Sirolimus
17 Recruiting Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Hypertension
Interventions: Procedure: renal sympathetic denervation;   Drug: antihypertensive drugs
18 Completed Effects of Somatostatin on Liver in ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: octeotride;   Drug: placebo
19 Completed
Has Results
Octreotide in Severe Polycystic Liver Disease
Conditions: Polycystic Kidney, Autosomal Dominant;   Polycystic Liver Disease;   Hepatomegaly;   Liver Diseases;   Kidney, Polycystic;   Abdominal Pain
Interventions: Drug: Octreotide;   Drug: Placebo
20 Recruiting Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: ADPKD
Interventions: Drug: Spironolactone;   Drug: Sugar pill

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years